BioNTech SE - ADR vs Logitech International SA — how do they compare? BioNTech SE - ADR trades at $92.23 (market cap $23.31B), while Logitech International SA trades at $103.82 (market cap $14.96B). The key difference: BioNTech SE - ADR is the larger of the two by market cap, and Logitech International SA pays a 1.64% dividend while BioNTech SE - ADR pays none. Which is the better fit depends on your goals.
| BNTX | LOGI | |
|---|---|---|
Market Cap | $23.31B | $14.96B |
Sector | Health | Technology |
52-Week High | $119.34 | $126.69 |
52-Week Low | $83.89 | $85.84 |
Enterprise Value | $6.60B | $13.30B |
Dividend Yield | — | 1.64% |
Trailing returns across standard periods
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Read more on BNTX →Logitech International SA is a Switzerland-based provider of personal computer and mobile accessories for navigation, video communication, and collaboration, smart home, and other applications. Its product portfolio includes mice, keyboards, charging stands, tablet cases, car mounts for mobile devices, remotes, home cameras, home switches, controllers, bluetooth speakers, surround sound, webcams, and conference cameras. It operates in a single segment namely, Peripherals. The firm generates revenue from the Americas, EMEA (Europe, Middle East, Africa), and the Asia Pacific region.
Read more on LOGI →